| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.08 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |